✦ LIBER ✦

Pivotal Trial to Evaluate the Safety and Efficacy of the Orbital Atherectomy System in Treating De Novo, Severely Calcified Coronary Lesions (ORBIT II)

✍ Scribed by Chambers, Jeffrey W.; Feldman, Robert L.; Himmelstein, Stevan I.; Bhatheja, Rohit; Villa, Augusto E.; Strickman, Neil E.; Shlofmitz, Richard A.; Dulas, Daniel D.; Arab, Dinesh; Khanna, Puneet K.; Lee, Arthur C.; Ghali, Magdi G.H.; Shah, Rakesh R.; Davis, Thomas P.; Kim, Christopher Y.; Tai, Zaheed; Patel, Kirit C.; Puma, Joseph A.; Makam, Prakash; Bertolet, Barry D.; Nseir, Georges Y.

Book ID: 124129713
Publisher: American College of Cardiology
Year: 2014
Tongue: English
Weight: 603 KB
Volume: 7
Category: Article
ISSN: 1936-8798
DOI: 10.1016/j.jcin.2014.01.158

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CRT-130 Gender Difference on Procedural

CRT-130 Gender Difference on Procedural and 30-day Outcomes in Patients Treated with Orbital Atherectomy for De-Novo, Severely Calcified Coronary Lesions: Results from the ORBIT II Trial

✍ Kim, Christopher; Chambers, Jeffrey W. 📂 Article 📅 2014 🏛 American College of Cardiology 🌐 English ⚖ 172 KB

TCT-643: Six Month Follow Up Data of Orb

TCT-643: Six Month Follow Up Data of Orbital Atherectomy System for the Treatment of De Novo Calcified Coronary Lesions (ORBIT I Trial)

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 438 KB

CRT-128 Comparing the Procedural and 30-

CRT-128 Comparing the Procedural and 30-Day Outcomes in Patients with or without a History of Coronary Artery Bypass Graft When Treating De Novo, Severely Calcified Coronary Lesions with Orbital Atherectomy: Results from ORBIT II

✍ Chambers, Jeffrey W.; Lee, Michael S.; Lee, Arthur C. 📂 Article 📅 2014 🏛 American College of Cardiology 🌐 English ⚖ 154 KB

A randomized, controlled, multi-center t

A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: Final results of the ZoMaxx II trial

✍ William A. Gray; Alan C. Yeung; Donald E. Cutlip; Jeffrey J. Popma; Peter J. Fit 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 382 KB

Long-Term Clinical and Economic Analysis

Long-Term Clinical and Economic Analysis of the Endeavor Drug-Eluting Stent Versus the Driver Bare-Metal Stent: 4-Year Results From the ENDEAVOR II Trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions)

✍ Eric L. Eisenstein; William Wijns; Jean Fajadet; Laura Mauri; Rex Edwards; Patri 📂 Article 📅 2009 🏛 American College of Cardiology 🌐 English ⚖ 364 KB

ABSORB II randomized controlled trial: A

ABSORB II randomized controlled trial: A clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: Rationale and study design

✍ Roberto Diletti; Patrick W. Serruys; Vasim Farooq; Krishnankutty Sudhir; Cecile 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 419 KB